- IDEC-Y2B8
- An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Also called yttrium Y90 ibritumomab tiuxetan.
English dictionary of cancer terms . 2015.